List of Excipients in API sacubitril and valsartan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing sacubitril and valsartan
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | CELLULOSE, MICROCRYSTALLINE | |
Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | CROSPOVIDONE | |
Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | FERRIC OXIDE RED | |
Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | FERROSOFERRIC OXIDE | |
Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED | |
Novartis Pharmaceuticals Corporation | ENTRESTO | sacubitril and valsartan | 0078-0659 | HYPROMELLOSES | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for sacubitril and valsartan
Excipient focus: CELLULOSE, MICROCRYSTALLINE
sacubitril and valsartan drug variants containing CELLULOSE, MICROCRYSTALLINE
sacubitril and valsartan drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
sacubitril and valsartan drug variants containing CROSPOVIDONE
sacubitril and valsartan drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
sacubitril and valsartan drug variants containing FERRIC OXIDE RED
sacubitril and valsartan drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
sacubitril and valsartan drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-806 |
>Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-807 |
Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-810 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
sacubitril and valsartan drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Novartis Pharmaceuticals Corporation | sacubitril and valsartan | 0078-0659 |
Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-807 |
Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-810 |
>Company | >Ingredient | >NDC |
sacubitril and valsartan drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Aphena Pharma Solutions - Tennessee LLC | sacubitril and valsartan | 71610-806 |
>Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
sacubitril and valsartan drug variants containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
sacubitril and valsartan drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
sacubitril and valsartan drug variants containing HYPROMELLOSES
sacubitril and valsartan drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
sacubitril and valsartan drug variants containing MAGNESIUM STEARATE
sacubitril and valsartan drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
sacubitril and valsartan drug variants containing POLYETHYLENE GLYCOL 4000
sacubitril and valsartan drug variants not containing POLYETHYLENE GLYCOL 4000
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
sacubitril and valsartan drug variants containing SILICON DIOXIDE
sacubitril and valsartan drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TALC
sacubitril and valsartan drug variants containing TALC
sacubitril and valsartan drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
sacubitril and valsartan drug variants containing TITANIUM DIOXIDE
sacubitril and valsartan drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.